Related Experiment Video
Updated: Oct 9, 2025

A Practical Guide for the Production and PET/CT Imaging of 68Ga-DOTATATE for Neuroendocrine Tumors in Daily Clinical Practice
Published on: April 17, 2019
Reducing the effect of proton pump inhibitors augmenting gastrointestinal sestamibi uptake
Joseph C Lee1,2, David S Rose3
1Department of Medical Imaging, The Prince Charles Hospital, Chermside, QLD, 4032, Australia. joseph.lee@health.qld.gov.au.
No abstract available in PubMed .
Related Concept Videos
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
However, this neutralization reaction between...
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Imaging Studies II: Positron Emission Tomography and Scintigraphy
Fundamental Principles of PET
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
![Automated Preparation of [68Ga]Ga-3BP-3940 on a Synthesis Module for PET Imaging of the Tumor Microenvironment](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F68356.jpg&w=3840&q=50)
